Ticker: AVIR

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has recently released its quarterly results for the period ending March 31, 2025. Below are key financial highlights and observations regarding the company’s financial standing. Income Statement Highlights: Total Operating Expenses: $39.0 million for Q1 ...